Members of the billionaire Sackler family will be protected from current and future lawsuits over their role in their Purdue Pharma’s opioid business, a New York court of appeals ruled Tuesday.

If approved, Purdue Pharma will contribute $900 million upfront while the Sackler family pays $6.5 billion over the next 15 years – a $500 million increase from the previous settlement.

The Guggenheim Museum’s education center—once named for the disgraced billionaire Sackler family before their fall from grace over their alleged role in the American opioid epidemic—will be ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication Oxycontin caused a widespread opioid ...

Purdue Pharma will go back to court Tuesday after the Supreme Court thwarted the OxyContin maker’s multibillion-dollar bankruptcy settlement, which would have shielded members of the Sackler ...

The Sackler family and its company, Purdue Pharma, reached a settlement with a coalition of 15 states in relation to their involvement in the United States opioid crisis. If approved, the January ...